|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
383978009 |
003 |
DE-627 |
005 |
20230905073609.0 |
007 |
tu |
008 |
040331s2004 xxu||||| 00| ||eng c |
016 |
7 |
|
|a 0781753562
|2 UK
|
020 |
|
|
|a 0781753562
|9 0-7817-5356-2
|
024 |
8 |
|
|a 2004005868
|q Identnummer
|
035 |
|
|
|a (DE-627)383978009
|
035 |
|
|
|a (DE-599)GBV383978009
|
035 |
|
|
|a (OCoLC)835122316
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
044 |
|
|
|c XD-US
|c XA-GB
|c XD-AR
|
050 |
|
0 |
|a RM315
|
060 |
|
0 |
|a QV 39
|
082 |
0 |
|
|a 615.78
|
084 |
|
|
|a 15,3
|2 ssgn
|
084 |
|
|
|a 44.38
|2 bkl
|
084 |
|
|
|a 44.91
|2 bkl
|
100 |
1 |
|
|a Pavuluri, Mani N.
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Handbook of psychopharmacotherapy
|b a life span approach
|c Mani N. Pavuluri ; Philip G. Janicak
|
264 |
|
1 |
|a Philadelphia, Pa. [u.a.]
|b Lippincott Williams & Wilkins
|c 2004
|
300 |
|
|
|a IX, 149 S
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Includes index
|
505 |
8 |
0 |
|a First generation antipsychotics -- Second generation antipsychotics -- First generation antidepressants -- Second generation antidepressants -- Mood stabilizers -- Antiepileptic agents -- Anxiolytics/ sedative-hypnotics -- Adjuvant medications -- Psychostimulants -- Anti-abuse agents appendices -- Miscellaneous medication -- Medication clinic progress note format -- Lithium laboratory monitoring -- Abnormal involuntary movement scale, modified -- Chicago "Adverse events checklist for children" -- Abbreviations
|
650 |
|
0 |
|a Psychopharmacology
|v Handbooks, manuals, etc
|
650 |
|
0 |
|a Pediatric psychopharmacology
|v Handbooks, manuals, etc
|
650 |
|
0 |
|a Geriatric psychopharmacology
|v Handbooks, manuals, etc
|
650 |
|
2 |
|a Psychotropic Drugs
|x pharmacology
|v Handbooks
|
650 |
|
2 |
|a Age Factors
|v Handbooks
|
650 |
|
2 |
|a Mental Disorders
|x drug therapy
|v Handbooks
|
689 |
0 |
0 |
|D s
|0 (DE-588)4236424-3
|0 (DE-627)104894520
|0 (DE-576)210396784
|a Psychopharmakotherapie
|2 gnd
|
689 |
0 |
|
|5 (DE-627)
|
700 |
1 |
|
|a Janicak, Philip G.
|4 oth
|
856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/383978009.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
856 |
4 |
2 |
|u http://www.loc.gov/catdir/enhancements/fy0712/2004005868-d.html
|x Verlag
|y Publisher description
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a ISIL_DE-84
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a SSG-OPC-DE-84
|
936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
936 |
b |
k |
|a 44.91
|j Psychiatrie
|j Psychopathologie
|0 (DE-627)106409972
|
951 |
|
|
|a BO
|
953 |
|
|
|2 045F
|a 615.78
|
980 |
|
|
|2 20
|1 01
|x 0084
|b 660880911
|c 00
|f --%%--
|d 2838-2234
|e --%%--
|j --%%--
|y k
|z 09-09-04
|
984 |
|
|
|2 20
|1 01
|x 0084
|a 84$028382234
|